Metformin

adiponectin, C1Q and collagen domain containing ; Homo sapiens







54 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35409282 Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS. 2022 Apr 1 1
2 34630103 Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study. 2021 2
3 34717078 Effect of metformin on adiponectin in PCOS: A meta-analysis and a systematic review. 2021 Dec 4
4 34764661 Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women. 2021 1
5 33520816 Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus. 2020 Dec 2
6 30334082 Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions. 2019 Jan 1
7 31570103 Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. 2019 Sep 30 2
8 31821361 Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study. 2019 1
9 29880175 The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study. 2018 Jun 1
10 30337733 [Effects of metformin and adiponectin on endometrial cancer cells growth]. 2018 Oct 18 3
11 27705028 Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs. 2017 Jan 1
12 28178338 The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox". 2017 1
13 28962190 Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus. 2017 Sep 5
14 28989873 Effect of Metformin-sustained Release Therapy on Low-density Lipoprotein Size and Adiponectin in the South Indian Women with Polycystic Ovary Syndrome. 2017 Sep-Oct 1
15 26808583 Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes. 2016 Feb 6
16 27036040 The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells. 2016 May 10 1
17 27085783 Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program. 2016 May 1
18 27600587 Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs. 2016 Oct 1
19 25377599 The impact of metformin treatment on adiponectin and resistin levels in women with polycystic ovary syndrome: a prospective clinical study. 2015 Feb 2
20 26473366 Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis. 2015 3
21 24251799 Changes in adiponectin level and fat distribution in patients with type 2 diabetes. 2014 Feb 2
22 24997826 Effect of piglitazone and metformin on retinol-binding protein-4 and adiponectin in patients with type 2 diabetes mellitus complicated with non-alcohol fatty acid liver diseases. 2014 Jun 1
23 25098218 [Metformin increases serum concentration of high molecular weight (HMW-adiponectin) in nondiabetic obese subjects]. 2014 Jul-Aug 2
24 25253174 Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial. 2014 Nov 1
25 23225237 Gender-dependent effects of metformin on vaspin and adiponectin in type 2 diabetes patients: a randomized clinical trial. 2013 Apr 2
26 23611575 A successful case of pain management using metformin in a patient with adiposis dolorosa. 2013 Jun 1
27 23875783 Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome. 2013 Dec 5
28 23979954 Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. 2013 Oct 1
29 24465050 The effects of gliclazide, metformin, and acarbose on body composition in patients with newly diagnosed type 2 diabetes mellitus. 2013 Dec 1
30 22342903 Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. 2012 Oct 1
31 22540883 Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes. 2012 Dec 1
32 22676459 Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? 2012 Jun 7 4
33 21031343 Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. 2011 Feb 1
34 21372608 In vitro and in vivo effects of metformin on human adipose tissue adiponectin. 2011 7
35 21455728 AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. 2011 Jul 1
36 21907790 Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system. 2011 Nov 15 3
37 22673924 Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. 2011 Nov 1
38 19996308 Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. 2010 Feb 1
39 19490068 Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity. 2009 Aug 1
40 18192541 Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. 2008 Apr 1
41 18606183 Regulation of AMP-activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. 2008 Sep 1
42 18645710 Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. 2008 Jul 1
43 18841263 A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. 2008 Oct 1
44 16953257 Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. 2007 Jan 1
45 17208384 Adipokines regulate systemic insulin sensitivity in accordance to existing energy reserves. 2007 4
46 17525501 Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes. 2007 Apr 3
47 19888409 Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. 2007 Mar 1
48 16624028 [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome]. 2006 Feb 4
49 16766204 Expanding role of AMPK in endocrinology. 2006 Jul 1
50 16839832 Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin. 2006 Aug 3